Submitted by web@researchtop... on Mon, 02/07/2022 - 16:23
Exploring the Current and Future Role of B-Cell Maturation Antigen-Directed Therapy in the Management of Multiple Myeloma (Faculty Presentations)
Jesús G Berdeja, MD
Director of Multiple Myeloma Research
Sarah Cannon Research Institute
Tennessee Oncology
Sarah Cannon Center for Blood Cancer
Nashville, Tennessee
Director of Multiple Myeloma Research
Sarah Cannon Research Institute
Tennessee Oncology
Sarah Cannon Center for Blood Cancer
Nashville, Tennessee
Noopur Raje, MD
Director, Center for Multiple Myeloma
Massachusetts General Hospital Cancer Center
Professor of Medicine
Harvard Medical School
Boston, Massachusetts